So that we can move back up to 80 where we belong?
Forbes has been on the auction block for months with no bids, even at salvage prices. The reason: Forbes is no longer a journal, but a website where none of the conributors are paid a nickel. (Think a downscale version of Seeking Alpha.) In fact, many of the "articles" on Forbes are advertisements in disguise, where the contributors actually pay to have their pieces posted. In other words, the opinions in Forbes are inherently even less reliable than the opinions posted here.
What is the rationale for selling in the cash account and holding the IRA positions? Gains in the cash account are obviously taxable in the year in which they're realized ... although in your case they are hopefully taxed at the longterm rate. Gains in the IRA are untaxed until you take a distribution, at which point they are subject to your ordinary income rate. I suppose your age may be a factor, but I would be inclined to give myself more flexibility by converting the cash account to a margin account, if possible.
I think someone has followed us over here from the ARNA board and has gambled a couple of hundred bucks on some cheap puts. Yup, MDVN, REGN, AMGN -- investors who own those stocks longterm are real saps. (Incidentally, it's spelled "venereal".)
Getting uglier and uglier. jan calls have lost over 60% of their value in last few sessions. another few million out of the pockets of the chumps and into the coffers of the mm's.
If this is your first biotech, you've unfortunately missed REGN, ONXX, MDVN, etc. A better approach to this segment, I think, is to buy many. EXEL is definitely one to own, I think.
Options suggest 13 tomorrow, through 13 decisively Monday. On another note,many here seem to have Ford as the major part of their portfolio. The answer is not to dump Ford and chase something else, I think, but to own a more diversified portfolio.
I pine for the days when Mark Haynes (sp?) and Erin injected some real humor and realism into that program.
Well, in fairness, he occasionally sticks his gecko neck out far enough to offer some advice for others -- notably his sage opinion on the DNDN board that the March15 calls were a safer bet than the February14's.
Which, if you believe, as many do, that MDV 3100 is a better drug, suggests that Medivation should be worth well north of $100 a share. A happy thought.
Awhile back, Barron's did a fairly exhaustive analysis of Cramer's stock picks. Their key conclusions were: (1) There were clear indications that his picks and pans had been disclosed to others in advance; and (2) the only way to consistently make money from his reco's was to bet against them (i.e short his picks, buy his pans). Remember that part of his disclaimer which says something like "his recommendations may have been previously disseminated". So, yes, it seems entirely plausible to me that some large players short Cramer's picks. After all, when he pumps a stock, he draws in small fish who are often buying on margin or speculating on options and are easily spooked. I have also often wondered about his assertion that his charitable trust holds positions in certain stocks. Do you suppose it's possible that some of his family members hold highly-paid positions on the board of his charitable trust? In the long run, Ford is too large and widely held an issue for Cramer to affect. He made his rep in the old days when he could pump some thinly traded small cap afterhours and drive it up 2 bucks. These days the program is largely a vehicle to peddle his books.
On the other hand, you could say that it's extremely unfortunate that the CEO still owns 176,000 shares, which means he's down roughly $600,000 today. Someone was bright enough to figure out that the relatively weak H1N1 pandemic would be bad for these guys and built up a large short position. To me, this doesn't seem to seriously diminish their longrange prospects. At the current price, they're paying a 3.8% dividend (somewhat more, if you adjust the price for that cash stash). Plus, they're still an attractive acquisition for someone. Let's see how low they can take it and buy some more near the close.
Well, Blair, from 11.67 in March of last year to 39.89 is a heck of a move. All longterm capital gains now, too. In my opinion, no reason not to hold it for years, unless it becomes a disproportionate part of your portfolio. Remember when we talked wistfully about the possibiilty of $20 a share?
I'm in Hawaii, Shaggy, admiring all the rental Fusions in the hotel parking lot, and pleasantly surprised by Ford's continued strength. I had a target price of $12 by May, $14 by yearend. Now I'll move it up to $14 by May, $16 by yearend. Thanks for another good link.